UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sustained virologic response after therapy with the HCV protease inhibitor narlaprevir in combination with peginterferon and ribavirin is durable through long-term follow-up

Journal of viral hepatitis, 2013-04, Vol.20 (4), p.e78-e81

2013

Volltextzugriff (PDF)

Repression by SSN6-TUP1 is directed by MIG1, a repressor/activator protein

Proceedings of the National Academy of Sciences - PNAS, 1995-04, Vol.92 (8), p.3132-3136

1995

Volltextzugriff (PDF)

A randomized, placebo-controlled study of the NS5B inhibitor beclabuvir with peginterferon/ribavirin for HCV genotype 1

Journal of viral hepatitis, 2015-08, Vol.22 (8), p.658-664

2015

Volltextzugriff (PDF)

Snf1 Protein Kinase Regulates Phosphorylation of the Mig1 Repressor in Saccharomyces cerevisiae

Molecular and Cellular Biology, 1998-11, Vol.18 (11), p.6273-6280

1998

Volltextzugriff (PDF)

Evolutionary dynamics of hepatitis C virus NS3 protease domain during and following treatment with narlaprevir, a potent NS3 protease inhibitor

Journal of viral hepatitis, 2013-11, Vol.20 (11), p.779-789

2013

Volltextzugriff (PDF)

844 IN VITRO CHARACTERIZATION OF THE PAN-GENOTYPE ACTIVITY OF THE HCV NS3/4A PROTEASE INHIBITORS BOCEPREVIR AND TELAPREVIR

Journal of hepatology, 2012-04, Vol.56, p.S329-S329

2012

Volltextzugriff (PDF)

11 SUSTAINED VIROLOGIC RESPONSE (SVR) IN PRIOR PEGINTERFERON/RIBAVIRIN (PR) TREATMENT FAILURES AFTER RETREATMENT WITH BOCEPREVIR (BOC)-+-PR: THE PROVIDE STUDY INTERIM RESULTS

Journal of hepatology, 2012-04, Vol.56, p.S6-S6

2012

Volltextzugriff (PDF)

Functional Interdependence of the Yeast SNF2, SNF5, and SNF6 Proteins in Transcriptional Activation

Proceedings of the National Academy of Sciences - PNAS, 1991-04, Vol.88 (7), p.2687-2691

1991

Volltextzugriff (PDF)

N-Terminal Mutations Modulate Yeast SNF1 Protein Kinase Function

Genetics (Austin), 1992-11, Vol.132 (3), p.639-650

1992

Volltextzugriff (PDF)

949 A SINGLE- AND MULTIPLE-DOSE ASSESSMENT OF THE SAFETY AND PHARMACOKINETICS OF SCH 900518 AND ITS EFFECT ON THE PHARMACOKINETICS OF MIDAZOLAM IN HEALTHY SUBJECTS

Journal of hepatology, 2009, Vol.50, p.S345-S345

2009

Volltextzugriff (PDF)

948 A REGIONAL GASTROINTESTINAL ABSORPTION STUDY OF THE HCV NS3 PROTEASE INHIBITOR SCH 900518 IN HEALTHY VOLUNTEERS

Journal of hepatology, 2009, Vol.50, p.S345-S345

2009

Volltextzugriff (PDF)

86 SAFETY AND ANTIVIRAL ACTIVITY OF SCH 900518 ADMINISTERED AS MONOTHERAPY AND IN COMBINATION WITH PEGINTERFERON ALFA-2B TO NAIVE AND TREATMENT-EXPERIENCED HCV-1 INFECTED PATIENTS

Journal of hepatology, 2009, Vol.50, p.S35-S36

2009

Volltextzugriff (PDF)

The SNF5 protein of Saccharomyces cerevisiae is a glutamine- and proline-rich transcriptional activator that affects expression of a broad spectrum of genes

Molecular and Cellular Biology, 1990-11, Vol.10 (11), p.5616-5625

1990

Volltextzugriff (PDF)

A randomized, placebo‐controlled study of the NS 5B inhibitor beclabuvir with peginterferon/ribavirin for HCV genotype 1

Journal of viral hepatitis, 2015-08, Vol.22 (8), p.658-664

2015

Volltextzugriff (PDF)

Evolutionary dynamics of hepatitis C virus NS 3 protease domain during and following treatment with narlaprevir, a potent NS 3 protease inhibitor

Journal of viral hepatitis, 2013-11, Vol.20 (11), p.779-789

2013

Volltextzugriff (PDF)

Short-term administration of the CCR5 antagonist vicriviroc to patients with HIV and HCV coinfection is safe and tolerable

Journal of acquired immune deficiency syndromes (1999), 2010-01, Vol.53 (1), p.78-85

2010

Volltextzugriff (PDF)

Electronic structure and spectra of .mu.-superoxo-dicobalt(III) complexes

Inorganic chemistry, 1975-10, Vol.14 (10), p.2318-2321

1975

Volltextzugriff (PDF)

Molecular and electronic structure of .mu.-nitrogen-decaamminediruthenium(II)

Journal of the American Chemical Society, 1969-11, Vol.91 (23), p.6512-6513

1969

Volltextzugriff (PDF)

Scenes in Bronze

College English, 1987-10, Vol.49 (6), p.650-651

Treitel, Margot

1987

Volltextzugriff (PDF)

Romance in West Africa

College English, 1986-01, Vol.48 (1), p.43-43

Treitel, Margot

1986

Volltextzugriff (PDF)

False Bravado

College English, 1985-04, Vol.47 (4), p.375-375

Treitel, Margot

1985

Volltextzugriff (PDF)

The Host Country's Language

College English, 1981-09, Vol.43 (5), p.493-493

Treitel, Margot

1981

Volltextzugriff (PDF)

Drop This Poem into the River Neva

College English, 1979-12, Vol.41 (4), p.409-409

Treitel, Margot

1979

Volltextzugriff (PDF)

SCHOPENHAUER'S PHILOSOPHY IN ITALO SVEVO'S "LA COSCIENZA DI ZENO"

Modern fiction studies, 1972-04, Vol.18 (1), p.53-64

Treitel, Renata Minerbi

1972

Volltextzugriff (PDF)

Reviews

Leading edge (Tulsa, Okla.), 2020-08, Vol.39 (8), p.601-602

2020

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(49)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sustained virologic response after therapy with the HCV protease inhibitor narlaprevir in combination with peginterferon and ribavirin is durable through long-term follow-up

Repression by SSN6-TUP1 is directed by MIG1, a repressor/activator protein

A randomized, placebo-controlled study of the NS5B inhibitor beclabuvir with peginterferon/ribavirin for HCV genotype 1

Snf1 Protein Kinase Regulates Phosphorylation of the Mig1 Repressor in Saccharomyces cerevisiae

Evolutionary dynamics of hepatitis C virus NS3 protease domain during and following treatment with narlaprevir, a potent NS3 protease inhibitor

844 IN VITRO CHARACTERIZATION OF THE PAN-GENOTYPE ACTIVITY OF THE HCV NS3/4A PROTEASE INHIBITORS BOCEPREVIR AND TELAPREVIR

11 SUSTAINED VIROLOGIC RESPONSE (SVR) IN PRIOR PEGINTERFERON/RIBAVIRIN (PR) TREATMENT FAILURES AFTER RETREATMENT WITH BOCEPREVIR (BOC)-+-PR: THE PROVIDE STUDY INTERIM RESULTS

Functional Interdependence of the Yeast SNF2, SNF5, and SNF6 Proteins in Transcriptional Activation

N-Terminal Mutations Modulate Yeast SNF1 Protein Kinase Function

949 A SINGLE- AND MULTIPLE-DOSE ASSESSMENT OF THE SAFETY AND PHARMACOKINETICS OF SCH 900518 AND ITS EFFECT ON THE PHARMACOKINETICS OF MIDAZOLAM IN HEALTHY SUBJECTS

948 A REGIONAL GASTROINTESTINAL ABSORPTION STUDY OF THE HCV NS3 PROTEASE INHIBITOR SCH 900518 IN HEALTHY VOLUNTEERS

86 SAFETY AND ANTIVIRAL ACTIVITY OF SCH 900518 ADMINISTERED AS MONOTHERAPY AND IN COMBINATION WITH PEGINTERFERON ALFA-2B TO NAIVE AND TREATMENT-EXPERIENCED HCV-1 INFECTED PATIENTS

The SNF5 protein of Saccharomyces cerevisiae is a glutamine- and proline-rich transcriptional activator that affects expression of a broad spectrum of genes

A randomized, placebo‐controlled study of the NS 5B inhibitor beclabuvir with peginterferon/ribavirin for HCV genotype 1

Evolutionary dynamics of hepatitis C virus NS 3 protease domain during and following treatment with narlaprevir, a potent NS 3 protease inhibitor

Short-term administration of the CCR5 antagonist vicriviroc to patients with HIV and HCV coinfection is safe and tolerable

Electronic structure and spectra of .mu.-superoxo-dicobalt(III) complexes

Molecular and electronic structure of .mu.-nitrogen-decaamminediruthenium(II)

Scenes in Bronze

Romance in West Africa

False Bravado

The Host Country's Language

Drop This Poem into the River Neva

SCHOPENHAUER'S PHILOSOPHY IN ITALO SVEVO'S "LA COSCIENZA DI ZENO"

Reviews

Suchergebnisse filtern